Subscribe to Legal

The Lead

Senator Warren to File Bill Targeting Top Pharma Companies

January 22, 2015 2:24 pm | by STEVE LeBLANC, Associated Press | News | Comments

Warren's bill would require that whenever drug companies enter into a settlement with the government over alleged wrongdoing, they must pay a portion of their annual profits over five years to support research at the NIH and the FDA.   

Fitch: SCOTUS Extends Patent Benefit for Teva; Generics Lose for Now

January 22, 2015 8:20 am | News | Comments

The Supreme Court (SCOTUS) decision that a federals appeals court wrongly overturned Teva...

Supreme Court Sides with Teva in Drug Dispute

January 21, 2015 8:11 am | by SAM HANANEL, Associated Press | News | Comments

The U.S. Supreme Court on Tuesday sided with Teva Pharmaceutical in the company's high-profile...

Survey: Healthcare and Life Science Companies Aware of But Not Prepared for Whistleblower Lawsuits

January 21, 2015 8:09 am | News | Comments

Many healthcare and life science companies are ill-prepared for federal "whistleblower" lawsuits...

View Sample

FREE Email Newsletter

Federal Judge Approves Consent Decree with California Dietary Supplement Maker

January 19, 2015 12:11 pm | News | Comments

A California dietary supplement manufacturer was ordered by a federal court to stop selling its products until the company comes into compliance with the U.S. Food and Drug Administration’s dietary supplement manufacturing regulations and other requirements listed in the consent decree.

Five Quick Questions: Biosimilar Regulatory and Intellectual Property Issues

January 15, 2015 1:50 pm | by Andrew Szal, Editor, Pharmaceutical Processing | Articles | Comments

As biologic drugs like Humira and Enbrel become a larger and larger part of the pharmaceutical market, a new report from attorneys at Goodwin Procter says the introduction of lower-cost generic versions called “biosimilars” may be close at hand. 

Hemispherx Biopharma Awarded $770,852 by Federal Judge

January 15, 2015 10:59 am | News | Comments

Hemispherx Biopharma announced that after prevailing in a federal lawsuit brought against the company by Cato Capital, the United States District Court for the District of Delaware has ordered Cato to pay Hemispherx attorney’s fees and costs in the amount of $770,852.76.


Sunovion Pharmaceuticals Files Patent Infringement Lawsuits Regarding Latuda®

January 14, 2015 4:09 pm | News | Comments

Sunovion Pharmaceuticals has filed patent infringement lawsuits against Emcure Pharmaceuticals Limited, Emcure Pharmaceuticals USA, Inc., and InvaGen Pharmaceuticals Inc. regarding their submissions of Abbreviated New Drug Applications for generic copies of Latuda®.

$18M Seized from Massachusetts Compounding Pharmacy Accounts

January 7, 2015 8:38 am | News | Comments

Authorities have seized over $18M from the owners of a Massachusetts compounding pharmacy at the center of a 2012 meningitis outbreak that killed 64 people nationwide. Attorney Carmen Ortiz said the funds were seized from 13 different financial institutions as a result of seizure warrants unsealed Tuesday.

Judge Orders Actavis to Continue Distribution of Alzheimer's Drug

January 7, 2015 8:20 am | News | Comments

A federal appeals court has left intact a judge's order for drug manufacturer Actavis PLC to keep distributing its widely used Alzheimer's medication.                 

Safeway Fined Nearly $10M for Illegal Disposal of Waste - Including Pharmaceuticals

January 6, 2015 1:16 pm | News | Comments

The Safeway supermarket chain has been ordered to pay nearly $10M for illegally dumping batteries, electronics and pharmaceuticals in California landfills. Alameda County District Attorney Nancy O'Malley says the practice occurred at more than 500 Safeway, Vons, Pavilions and Pak 'n Save stores and distribution sites throughout California for more than seven years.

Illinois Extends Marijuana Experiment to Children

January 2, 2015 3:21 pm | by CARLA K. JOHNSON, AP Medical Writer | News | Comments

A new law expanding the Illinois medical marijuana program to children is opening a market for an unproven strain of cannabis called Charlotte's Web and a dark green, weed-fragrant oil made from it. Some parents of children with epilepsy say the oil eases their children's seizures.


Judge Delivers Blow to Maker of Alzheimer's Drug

January 2, 2015 9:11 am | Videos | Comments

The maker of the Alzheimer's drug Namenda announced it would stop selling the drug and was moving patients to a newer version called Namenda XR. But New York's attorney general filed a lawsuit, saying the practice blocked competition and was illegal.

Massachusetts Attorney General-Elect May Target Drug Companies

January 2, 2015 8:23 am | by STEVE LeBLANC, Associated Press | News | Comments

Attorney General-elect Maura Healey says she would consider taking legal action against pharmaceutical companies to help rein in prescription drug abuse that can lead to heroin addiction.           

Court Rules Inventors Correctly Named on Androxal(R) Patents

December 29, 2014 10:18 am | News | Comments

Repros Therapeutics Inc. has announced a federal judge in Texas has issued a definitive ruling finding correct inventorship for two Repros Therapeutics Androxal(R) patents, thus confirming that Repros Therapeutics is the sole and rightful owner of the patents, U.S. Patent No. 7,759,360 (the "'360 patent") and U.S. Patent No. 7,737,185 (the "'185 patent").

FDA Targeting Sellers of Pure Caffeine Powder

December 23, 2014 8:22 am | by MARY CLARE JALONICK, Associated Press | News | Comments

The FDA is building a legal case against companies that sell pure powdered caffeine, which can be fatal even in small doses. The FDA warned consumers to avoid pure powdered caffeine this summer after the death of an Ohio teen. Some major retailers have stopped selling it in bulk, but the substance is still widely available on the Internet and in some stores.

Consumer Group Sues Aetna, Alleges Discrimination

December 23, 2014 8:09 am | by JULIE WATSON, Associated Press | News | Comments

A consumer advocacy group has filed a class-action lawsuit against Aetna Inc. saying a new policy violates the privacy of people with HIV and AIDS by requiring them to get their medications from its mail-order pharmacy.      


Home Confinement Ordered for Ex-Pharmacy Officials

December 22, 2014 8:15 am | News | Comments

A federal judge on Friday ordered home confinement and GPS monitoring for two former officials with a now-defunct Massachusetts compounding pharmacy at the center of a 2012 fungal meningitis outbreak that killed 64 people and sickened more than 750 others across the country.

Supplement Maker Lied About Ingredients

December 18, 2014 8:47 am | News | Comments

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.               

Painkillers Lawsuit Against NFL Dismissed

December 18, 2014 8:40 am | News | Comments

A federal judge dismissed a lawsuit by 1,300 former players against the NFL, writing that the collective bargaining agreement between the league and the union was the appropriate forum to resolve claims that teams damaged the players' by routinely dispensing painkillers.

Fourteen Charged for Roles in Meningitis Outbreak

December 17, 2014 12:04 pm | by DENISE LAVOIE, Associated Press | News | Comments

Fourteen owners or employees of a Massachusetts pharmacy were charged Wednesday in connection with a 2012 meningitis outbreak that killed 64 people nationwide and was traced to tainted drug injections.        

Judge Halts Alzheimer's Drug Swap Until July

December 16, 2014 8:47 am | by MICHAEL VIRTANEN, Associated Press | News | Comments

U.S. District Judge Robert Sweet told Dublin-based Actavis PLC to continue making the drug Namenda available for 30 days after generic alternatives become available on July 11 "in order to allow for an orderly transition."     

Actavis to Appeal Injunction Requiring Continued Distribution of NAMENDA IR

December 15, 2014 3:32 pm | News | Comments

Actavis confirmed that it is filing an emergency appeal to the U.S. Court of Appeals for the Second Circuit seeking to immediately overturn a lower court ruling requiring the Company to continue distribution of NAMENDA (memantine HCl) immediate-release tablets.

Justices Reject Arizona Bid Over Abortion Drugs

December 15, 2014 1:49 pm | News | Comments

The justices left in place a lower court ruling that blocked rules that regulate where and how women can take drugs that induce abortion. The rules also would prohibit the use of the abortion medications after the seventh week of pregnancy instead of the ninth.

New York Judge Halts Alzheimer's Drug Swap

December 15, 2014 8:35 am | News | Comments

New York's attorney general says a drug manufacturer has been ordered to halt plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.        

Judge: Texas Must Reveal Execution Drug Maker

December 15, 2014 8:21 am | by WILL WEISSERT, Associated Press | News | Comments

District Judge Darlene Byrne rejected arguments from the Texas Department of Criminal Justice. The agency argued that the name of the company should be kept secret for public security reasons.          

Prosecutor: Chances of February Execution 'Nil'

December 11, 2014 2:36 pm | by ANDREW WELSH-HUGGINS, AP Legal Affairs Writer | News | Comments

A prosecutor says he expects lawsuits following the passage of an updated lethal injection law that will make it impossible to carry out the Feb. 11 execution of a condemned child killer as planned.         

Gilead Faces Lawsuit Over Hepatitis C Drug Pricing

December 11, 2014 1:59 pm | by The Associated Press | News | Comments

Philadelphia's Transportation Authority has filed a lawsuit against Gilead Sciences over the pricing of its hepatitis C drug. Gilead has been selling a 12-week treatment of Sovaldi in the United States for approximately $84,000, or $1,000 per pill.

Ohio Lawmakers Narrow Lethal Injection Bill

December 10, 2014 1:32 pm | by ANDREW WELSH-HUGGINS, AP Legal Affairs Writer | News | Comments

At issue was a requirement that would have told drugmakers they couldn't restrict distribution of drugs that could be used in executions. Opponents of the requirement expected the European Union would quickly ban the export of the anesthetic propofol to the U.S. if Ohio's bill became law.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.